Cougar's prostate cancer hope abiraterone shows early promise
This article was originally published in Scrip
Executive Summary
Cougar Biotechnology's lead compound, a novel hormonal treatment for prostate cancer, has shown benefit in a Phase I study published in the Journal of Clinical Oncology.